133481-09-1,
2-(1-cyanocyclohexyl)acetic Acid,
1-cyanocyclohexaneacetic acid,
(1-Cyanocyclohexyl)acetic acid,
UNII-E1393FZ76L,
Cyclohexaneacetic acid,1-cyano-,
(1-Cyanocyclohexyl)-acetic acid,
E1393FZ76L,
gabapentin usp rc b,
ACMC-20aa2u,
gabapentin related material b,
SCHEMBL840651,
CTK4B8557,
Cyclohexaneacetic acid, 1-cyano-,
DTXSID40158130,
YGFXLCAKCKPSQQ-UHFFFAOYSA-N,
BCP04520,
ZINC2529197,
6091AA,
ANW-63988,
MFCD04117948,
AKOS006291872,
VZ21391,
AJ-38404,
AK-58083,
AN-32142,
SC-52685,
RT-022599,
FT-0657196,
481C091,
I04-0509,
J-006389,
(1-Cyanocyclohexyl)acetic acid, analytical reference material,
Gabapentin impurity B, European Pharmacopoeia (EP) Reference Standard,
Gabapentin Related Compound B, United States Pharmacopeia (USP) Reference Standard,
(1-CYANOCYCLOHEXYL)ACETIC ACID(Gabapentin Related Compound B)(Gabapentin Impurity B), Pharmaceutical Secondary Standard; Certified Reference Material,
cc-628,
Gabapentin Related Compound B,
C9H13NO2,
1-CYANOCYCLOHEXANE ACETIC ACID,
CID11073797,